Robert Abrams

About

Rob Abrams has over 27 years of experience in biomedical device product development, research, operational management, new business development and strategic investments. Rob joined Sanderling as an Operating Partner in April 2008. Prior to joining Sanderling, Rob served 12 years at Boston Scientific Corp. as Group Vice President of New Business Development for BSC’s Cardiovascular Group Divisions, which included Neurovascular, Cardiac Surgery, Neuromodulation, Electrophysiology, and Peripheral Interventional Divisions. In this role, he also served on executive management boards, and patent and legal review boards. During his tenure at BSC, Rob completed acquisition of Smart Therapeutics, Inc. for intracranial stents, and other minimally invasive access devices, Precision Vascular Systems, Inc. a steerable guidewire/catheter company, and several neuromodulation companies, including acquisition of Advanced Bionics Corp. He also led the corporate program to explore technology for acute

Investment Focus